957346-35-9

Basic information

• Product Name: methyl 4-bromo-2-fluoro-6-nitromethylbenzoate
• Synonyms: methyl 4-bromo-2-fluoro-6-nitromethylbenzoate
• CAS NO: 957346-35-9
• Molecular Weight: 292.061
• Mol File: 957346-35-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: methyl 4-bromo-2-fluoro-6-nitromethylbenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 4-bromo-2-fluoro-6-nitromethylbenzoate(957346-35-9)
• EPA Substance Registry System: methyl 4-bromo-2-fluoro-6-nitromethylbenzoate(957346-35-9)

Safety Data

• Hazardous Substances Data: 957346-35-9(Hazardous Substances Data)

Upstream product

• 497181-19-8 2,6-difluoro-4-bromobenzoyl chloride 
• 183065-68-1 4-bromo-2,6-difluorobenzoic acid 
• 773134-11-5 4-bromo-2,6-difluorobenzoic acid methyl ester 
• 75-52-5 nitromethane 

Downstream Products

• 957346-37-1 5-bromo-7-fluoro-2,3-dihydro-1H-isoindol-1-one 
• 1569023-16-0 C₉H₉BrFNO₂ 
• 957346-40-6 7-fluoro-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-2,3-dihydroisoindol-1-one 

Relevant articles and documents

HIGHLY SELECTIVE C-MET INHIBITORS AS ANTICANCER AGENTS

Disclosed are novel nitrogen-containing, heterocyclic, c-Met inhibitor compounds, processes for their preparation and formulations thereof. The compounds are useful as therapeutical agents for the inhibition, regulation, and control of c-Met kinase signal pathway, and useful for treating in a subject a cell proliferative disorder or disorders mediated by c-Met.

IMIDAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

Novel imidazo[1,2-a]pyrazine compounds are disclosed that have a formula ( I ) represented by the following:The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, arthritis, inflammation, and others.